Geistlich Pharma India Pvt. Ltd.

Geistlich Pharma India Pvt. Ltd. company information, Employees & Contact Information

Geistlich Pharma India Pvt. Ltd. is a wholly owned subsidiary of Geistlich Pharma AG. Geistlich Pharma AG develops, manufactures & market medical products for restoring bone, cartilage & soft tissue and offers medicinal and medical products in selected dental & orthopaedic applications. The Swiss company operates from Wolhusen & encompasses three business units: Geistlich Biomaterials, Geistlich Surgery & Geistlich Medical. Geistlich Pharma is a part of Geistlich group which has been family owned since 1851. Geistlich Biomaterials specialises is regenerative biomaterials for 30 years and has long been the world market leader in regenerative dentistry. Geistlich Bio-Oss & Geistlich Bio-Gide are pioneer products in bone regeneration. More than 1,000 scientific publications in the specialist press document the clinical use of Geistlich products. For more information about the product & courses on Guided Bone Regeneration; Peri-Implantitis; Sinus Floor Elevation; Ridge Augmentation & Socket Preservation etc. contact us at toll free no. 18002701325 or mail us at info@geistlich.in

Company Details

Employees
26
Address
Dsm - 161 & 162, 1st Floor, Dlf Towers, 15 Shivaji Marg, Main Najafgarh Road, New Delhi,delhi 110015,india
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
NEW DELHI, DELHI
Looking for a particular Geistlich Pharma India Pvt. Ltd. employee's phone or email?

Geistlich Pharma India Pvt. Ltd. Questions

News

Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States - BioSpace

Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States BioSpace

StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio - PR Newswire

StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio PR Newswire

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover - Business Wire

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover Business Wire

CN09 - Beijing AMR fines pharmaceutical company CNY 9 million for RPM conduct - Ashurst

CN09 - Beijing AMR fines pharmaceutical company CNY 9 million for RPM conduct Ashurst

Gabathuler becomes new CEO of Geistlich - Dental Tribune US

Gabathuler becomes new CEO of Geistlich Dental Tribune US

Geistlich Pharma North America Acquires Lynch Biologics - Dentistry Today

Geistlich Pharma North America Acquires Lynch Biologics Dentistry Today

New products: Geistlich launches 2 new collagen membranes - DrBicuspid.com

New products: Geistlich launches 2 new collagen membranes DrBicuspid.com

Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award - PR Newswire

Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award PR Newswire

Geistlich unveils vallos™ - a new demineralized allograft that sets the pace for regeneration - BioSpace

Geistlich unveils vallos™ - a new demineralized allograft that sets the pace for regeneration BioSpace

Geistlich Pharma North America, Inc. Release: Geistlich Bio-Oss Portfolio Expands - BioSpace

Geistlich Pharma North America, Inc. Release: Geistlich Bio-Oss Portfolio Expands BioSpace

Full Availability of Geistlich Fibro-Gide®, The Alternative Soft-Tissue Graft - BioSpace

Full Availability of Geistlich Fibro-Gide®, The Alternative Soft-Tissue Graft BioSpace

Geistlich announces the dramatic expansion of their allograft portfolio - vallos® sets the pace for regeneration - PR Newswire

Geistlich announces the dramatic expansion of their allograft portfolio - vallos® sets the pace for regeneration PR Newswire

25 Year Follow up with Geistlich Bio-Oss Collagen® - PR Newswire

25 Year Follow up with Geistlich Bio-Oss Collagen® PR Newswire

Geistlich Biomaterials Launches The Alternative Soft-Tissue Graft - PR Newswire

Geistlich Biomaterials Launches The Alternative Soft-Tissue Graft PR Newswire

Trust Us: Introducing The Geistlich Guarantee - PR Newswire

Trust Us: Introducing The Geistlich Guarantee PR Newswire

Geistlich Pharma North America, Inc. launches a complete line of Bone Harvesting Instruments - PR Newswire

Geistlich Pharma North America, Inc. launches a complete line of Bone Harvesting Instruments PR Newswire

Geistlich Immobilia ernennt Ladina Esslinger zur Geschäftsführerin - IMMOBILIEN Business

Geistlich Immobilia ernennt Ladina Esslinger zur Geschäftsführerin IMMOBILIEN Business

HANSAmed Limited Introduces Geistlich Fibro-Gide®: The Alternative Soft-Tissue Graft - Oral Health Group

HANSAmed Limited Introduces Geistlich Fibro-Gide®: The Alternative Soft-Tissue Graft Oral Health Group

Geistlich dental products to be available in India - ET HealthWorld

Geistlich dental products to be available in India ET HealthWorld

Schlieren: Grundsteinlegung für Neubau auf dem Geistlich Areal - IMMOBILIEN Business

Schlieren: Grundsteinlegung für Neubau auf dem Geistlich Areal IMMOBILIEN Business

Geistlich Pharma AG Acquires Minority Stake in TRI Dental Implants Int. AG - Global Legal Chronicle

Geistlich Pharma AG Acquires Minority Stake in TRI Dental Implants Int. AG Global Legal Chronicle

Top Geistlich Pharma India Pvt. Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant